Surface treatment agent for copper or copper alloy

By using chemically generated coatings formed by using imidazole compounds and triazole compounds of specific structures on the copper surface of the printed wiring board, the problems of poor wetting and high-temperature oxidation of lead-free solder on the copper surface are solved, and the welding performance and heat resistance are improved .

CN118922584APending Publication Date: 2024-11-08SHIKOKU CHEM CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380030322.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-29
Filing Date
2023-03-24
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing lead-free solder has poor wetting properties on the copper surface, resulting in poor soldering properties, and oxidation is prone to occur at high temperatures, affecting the welding performance of printed wiring boards.

Method used

The surface treatment agent containing an imidazole compound or a benzimidazole compound and a triazole compound having a specific structure are used as an auxiliary agent to form a chemically generated coating with excellent heat resistance and improve the weldability of the copper surface.

Benefits of technology

It significantly improves the wetting and welding performance of lead-free solder to the copper surface, enhances the resistance to high temperature, and ensures the welding quality of the printed wiring board.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118922584A_ABST
    Figure CN118922584A_ABST
Patent Text Reader

Abstract

The present invention addresses the problem of providing a surface treatment agent which has excellent heat resistance of a chemically generated coating film formed on a copper surface and which is capable of obtaining good weldability during welding. This copper or copper alloy surface treatment agent contains an imidazole compound represented by chemical formula (I) or a benzimidazole compound represented by chemical formula (II) and a triazole compound represented by chemical formula (III). The definitions of the substituents in the chemical formulae (I)-(III) are the same as the definitions in the description. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a surface treatment agent for copper or copper alloy used for a printed wiring board. Background Art

[0002] Recently, surface mounting with improved mounting density has been widely used as a mounting method for printed wiring boards. Such surface mounting methods are divided into double-sided surface mounting in which chip components are bonded using solder paste, and hybrid mounting in which surface mounting of chip components using solder paste and through-hole mounting of discrete components are combined. In any mounting method, the printed wiring board is soldered multiple times, so it is exposed to high temperatures each time and is subjected to severe thermal history.

[0003] As a result, the surface of copper or copper alloy (hereinafter sometimes simply referred to as copper) constituting the circuit portion of the printed wiring board is heated, and the formation of an oxide film is promoted, so that the solderability of the circuit portion surface cannot be maintained well.

[0004] In order to protect the copper circuit portion of such a printed wiring board from being oxidized by air or heat, a process of forming a chemically generated coating on the surface of the copper circuit portion using a surface treatment agent (preflux) is widely performed. The chemically generated coating formed by the surface treatment agent, called an OSP (Organic Solderability Preservative) film, is required to protect the copper circuit portion without modification (deterioration) even after the copper circuit portion is subjected to multiple thermal histories, thereby maintaining good solderability.

[0005] On the other hand, eutectic solder of tin-lead alloy has been widely used in the past when joining electronic components to printed wiring boards, etc. However, in recent years, there have been concerns about the harmfulness of lead (Pb) contained in this solder alloy to the human body, and the use of lead-free solder has been required.

[0006] To this end, various lead-free solders have been studied. For example, lead-free solders have been proposed that use tin (Sn) as a base metal and add metals such as silver (Ag), zinc (Zn), bismuth (Bi), indium (In), antimony (Sb), cobalt (Co), manganese (Mn), nickel (Ni), and copper (Cu).

[0007] However, the conventional Sn—Pb-based eutectic solder has excellent wettability to the surface of the metal used for the bonding base material, particularly copper, and is firmly bonded to copper, so that high reliability can be obtained in the bonding between copper members.

[0008] In contrast, lead-free solder has poor wettability on the surface of copper compared to conventional Sn-Pb-based eutectic solder, and therefore has poor solderability, resulting in bonding defects such as voids, and low bonding strength.

[0009] Therefore, when using lead-free solder, it is required to select a solder alloy with better solderability and a flux suitable for lead-free solder. The surface treatment agent used to prevent oxidation of the copper surface is also required to have the function of improving the wettability of the lead-free solder and improving the solderability.

[0010] Furthermore, many lead-free solders have high melting points and soldering temperatures that are about 20°C to 50°C higher than conventional Sn-Pb-based eutectic solders, and therefore it is desired to form a chemical conversion coating having excellent heat resistance with the surface treatment agent.

[0011] Various studies have been conducted using imidazole compounds as active ingredients in such surface treatment agents. For example, Patent Documents 1 and 2 propose surface treatment agents for copper or copper alloys containing imidazole compounds having specific substituents.

[0012] Prior art literature

[0013] Patent Literature

[0014] Patent Document 1: Japanese Patent Application Publication No. 2012-241251

[0015] Patent Document 2: Japanese Patent Application Publication No. 2013-1977 Summary of the invention

[0016] Problems to be solved by the invention

[0017] In order to improve the performance of electronic devices, it is required to maintain good solderability of electronic components to printed wiring boards. In particular, when lead-free solder is used, it is required to further improve the surface treatment agent in order to prevent oxidation of the copper surface.

[0018] Therefore, an object of the present invention is to provide a surface treatment agent that can provide a chemical conversion coating formed on a copper surface with excellent heat resistance and good solderability during soldering.

[0019] Means for solving problems

[0020] The present inventors have repeatedly conducted intensive studies to solve the above-mentioned problems and have found that the above-mentioned problems can be solved by treating a printed wiring board having a copper circuit portion with a surface treatment agent that uses an imidazole compound or a benzimidazole compound of a specific structure and also contains a triazole compound of a specific structure as an auxiliary agent, thereby completing the present invention.

[0021] That is, the present invention is as described in the following [1] to [6].

[0022] [1] A surface treatment agent for copper or a copper alloy, wherein the surface treatment agent contains

[0023] An imidazole compound represented by the following chemical formula (I) or a benzimidazole compound represented by the following chemical formula (II), and

[0024] A triazole compound represented by the following chemical formula (III).

[0025]

[0026] (In formula (I),

[0027] R1 represents a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a cycloalkyl group, a phenyl group which may have a substituent, a naphthyl group which may have a substituent, a benzyl group which may have a substituent, a naphthylmethyl group, -CH-(Ph)2, -(CH2) k -Ph, thienyl, thienylmethyl, furyl or pyridyl, wherein Ph represents a phenyl group which may have a substituent, and k represents an integer of 2 to 5.

[0028] R2 are the same or different and represent a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a cycloalkyl group, a phenyl group which may have a substituent, a naphthyl group which may have a substituent, a thienyl group or a furyl group. However, the case where R2 is a hydrogen atom at the same time is excluded.)

[0029]

[0030] (In formula (II),

[0031] R3 represents a linear or branched alkyl group having 1 to 18 carbon atoms, -(CH2) m -Ph, -(CH2) m -Np or a group represented by the following formula (1), Ph represents a phenyl group which may have a substituent, Np represents a naphthyl group which may have a substituent, and m represents an integer of 1 to 5.

[0032]

[0033] (In formula (1), m represents an integer of 1 to 5.)

[0034] R4 are the same or different and represent a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a nitro group or a halogen atom.

[0035]

[0036] (In formula (III),

[0037] R5 and R6 are the same or different and represent a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, an amino group, a phenyl group which may have a substituent, a benzyl group, a naphthyl group, a pyridyl group which may have a substituent, or a group represented by the following formula (2). However, this does not apply to the case where both R5 and R6 are groups represented by the following formula (2).

[0038]

[0039] (In formula (2), t represents an integer from 0 to 12.)

[0040] R7 represents a hydrogen atom, a benzyl group or -(CH2) n -COOH, n represents an integer of 1 to 5. )

[0041] [2] The surface treatment agent for copper or copper alloy according to [1], wherein the surface treatment agent further contains halide ions.

[0042] [3] The surface treatment agent for copper or copper alloy according to [2], wherein the halide ion is a chloride ion.

[0043] [4] The surface treatment agent for copper or copper alloy according to any one of [1] to [3], wherein the surface treatment agent further contains zinc ions.

[0044] [5] A surface treatment agent for copper or copper alloy as described in any one of [1] to [4], wherein the triazole compound represented by the chemical formula (III) is contained in a molar ratio of 0.005 to 3.0 relative to the imidazole compound represented by the chemical formula (I) or the benzimidazole compound represented by the chemical formula (II).

[0045] [6] The surface treatment agent for copper or copper alloy according to any one of [1] to [5], wherein the pH of the surface treatment agent is 2 to 5.

[0046] Effects of the Invention

[0047] The surface treatment agent for copper or copper alloy of the present invention can form a chemical conversion coating having excellent heat resistance on the surface of copper or copper alloy constituting the circuit portion of a printed wiring board, etc., and can significantly improve the wettability of the solder to the surface, thereby improving solderability. DETAILED DESCRIPTION

[0048] Hereinafter, the present invention will be described in detail. However, it should be noted that the present invention is not limited to the embodiments described below.

[0049] The surface treatment agent for copper or copper alloy of the present invention is a surface treatment agent (water-soluble preflux) containing an imidazole compound represented by formula (I) or a benzimidazole compound represented by formula (II) as an effective ingredient and a triazole compound represented by formula (III) as an auxiliary agent.

[0050] When the surface treatment agent of the present invention is attached to copper or copper alloy, the copper ions dissolved from the copper surface react with the imidazole compound represented by formula (I) or the benzimidazole compound represented by formula (II) to form a copper-imidazole complex. Since the copper-imidazole complex is insoluble in the surface treatment agent, it is deposited on the copper or copper surface to form a chemically generated coating (OSP film). By containing a triazole compound represented by formula (III) in the surface treatment agent, although its effect is unclear, it is speculated that by introducing the triazole compound into the chemically generated coating, the heat resistance of the chemically generated coating is improved.

[0051] (Imidazole compound represented by formula (I))

[0052] The imidazole compound represented by the formula (I) (hereinafter, sometimes referred to as imidazole compound (I)) has the following structure.

[0053]

[0054] (In formula (I),

[0055] R1 represents a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a cycloalkyl group, a phenyl group which may have a substituent, a naphthyl group which may have a substituent, a benzyl group which may have a substituent, a naphthylmethyl group, -CH-(Ph)2, -(CH2) k -Ph, thienyl, thienylmethyl, furyl or pyridyl, wherein Ph represents a phenyl group which may have a substituent, and k represents an integer of 2 to 5.

[0056] R2 are the same or different and represent a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a cycloalkyl group, a phenyl group which may have a substituent, a naphthyl group which may have a substituent, a thienyl group or a furyl group. However, the case where R2 is a hydrogen atom at the same time is excluded.)

[0057] In formula (I), R1 is a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a cycloalkyl group, a phenyl group which may have a substituent, a naphthyl group which may have a substituent, a benzyl group which may have a substituent, a naphthylmethyl group, -CH-(Ph)2 (Ph is a phenyl group which may have a substituent), -(CH2) k -Ph (Ph is a phenyl group which may have a substituent, and k is an integer of 2 to 5), thienyl, thienylmethyl, furyl or pyridyl.

[0058] Specific examples of the linear alkyl group having 1 to 18 carbon atoms include methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, etc. Branched alkyl groups having 1 to 18 carbon atoms are branched alkyl groups having 3 to 18 carbon atoms, and specific examples thereof include isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, sec-pentyl, tert-pentyl, isohexyl, sec-hexyl, tert-hexyl, isoheptyl, sec-heptyl, tert-heptyl, isooctyl, sec-octyl, tert-octyl, etc.

[0059] Examples of the substituent replacing the hydrogen of the phenyl group, naphthyl group and benzyl group include a linear or branched alkyl group having 1 to 18 carbon atoms, a phenyl group, a methoxy group, an ethoxy group and a halogen atom.

[0060] Examples of the halogen atom that replaces hydrogen in the phenyl, naphthyl, and benzyl groups include fluorine atom (F), chlorine atom (Cl), bromine atom (Br), and iodine atom (I). Examples of the phenyl group substituted with a halogen atom include 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl, 2-iodophenyl, 3-iodophenyl, 4-iodophenyl, 2,3-dichlorophenyl, 2,4-dichlorophenyl, 2,5-dichlorophenyl, 2,6-dichlorophenyl, 3,4-dichlorophenyl, 3,5-dichlorophenyl, 2,4,5-trichlorophenyl, and 3,4,5-trichlorophenyl. Specific examples of the benzyl group substituted with a halogen atom include 2-fluorobenzyl, 3-fluorobenzyl, 4-fluorobenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl, 2-bromobenzyl, 3-bromobenzyl, 4-bromobenzyl, 2-iodobenzyl, 3-iodobenzyl, 4-iodobenzyl, 2,3-dichlorobenzyl, 2,4-dichlorobenzyl, 2,5-dichlorobenzyl, 2,6-dichlorobenzyl, 3,4-dichlorobenzyl, 3,5-dichlorobenzyl, 2,4,5-trichlorobenzyl, and 3,4,5-trichlorobenzyl.

[0061] Examples of the thienyl group include 2-thienyl and 3-thienyl, and examples of the furyl group include 2-furyl and 3-furyl.

[0062] From the viewpoint of heat resistance of the chemically generated film, R1 is preferably a linear or branched alkyl group having 1 to 18 carbon atoms, a phenyl group which may have a substituent, a naphthyl group which may have a substituent, a benzyl group which may have a substituent, a naphthylmethyl group, or a thienyl group.

[0063] R2 is a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a cycloalkyl group, a phenyl group which may have a substituent, a naphthyl group which may have a substituent, a thienyl group or a furyl group. These substituents are the same as the substituents described in the above R1. The two R2s may be the same or different, and R2s may not be hydrogen atoms at the same time.

[0064] From the viewpoint of heat resistance of the chemically generated film, R2 is preferably a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a phenyl group which may have a substituent, a naphthyl group which may have a substituent, a thienyl group, or a furyl group, except when R2 is also a hydrogen atom.

[0065] As the imidazole compound represented by the formula (I) (imidazole compound (I)), imidazole compounds represented by the formula (I-1) to the formula (I-6) are preferred.

[0066]

[0067] (In formula (I-1), R 112 represents a linear or branched alkyl group having 1 to 18 carbon atoms, R 214 represents a linear or branched alkyl group having 1 to 18 carbon atoms or a phenyl group which may have a substituent, R 215 It represents a hydrogen atom or a linear or branched alkyl group having 1 to 18 carbon atoms.

[0068] In formula (I-2), R 224 represents a phenyl group which may have a substituent, a naphthyl group which may have a substituent, a thienyl group or a furyl group, and R 225 represents a hydrogen atom or a linear or branched alkyl group having 1 to 18 carbon atoms, R 226 are the same or different and represent a linear or branched alkyl group having 1 to 18 carbon atoms, a methoxy group, an ethoxy group or a halogen atom; and p represents an integer of 0 to 3.

[0069] In formula (I-3), R 234 represents a phenyl group which may have a substituent, R 235 It represents a hydrogen atom or a linear or branched alkyl group having 1 to 18 carbon atoms.

[0070] In formula (I-4), R 244 represents a phenyl group, a naphthyl group or a thienyl group which may have a substituent, R 245 represents a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, or a phenyl group which may have a substituent, and R 246 are the same or different, represent a linear or branched alkyl group having 1 to 18 carbon atoms, or a halogen atom, and p represents an integer of 0 to 3.

[0071] In formula (I-5), R 254 represents a phenyl group which may have a substituent, R 255 It represents a hydrogen atom or a linear or branched alkyl group having 1 to 18 carbon atoms.

[0072] In formula (I-6), R 264 represents a phenyl group or a naphthyl group which may have a substituent, R 265 represents a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, or a phenyl group which may have a substituent.

[0073] Specific examples of the imidazole compound (I) include the imidazole compound represented by the formula (I-1):

[0074] 2-ethyl-4-methylimidazole,

[0075] 2-Undecyl-4-methylimidazole,

[0076] 2,4,5-Trimethylimidazole,

[0077] 4,5-Dimethyl-2-octylimidazole,

[0078] 4-(3,4-dichlorophenyl)-5-methyl-2-nonylimidazole,

[0079] 4-(2,4-dichlorophenyl)-5-methyl-2-undecylimidazole, etc.

[0080] Examples of the imidazole compound represented by formula (I-2) include:

[0081] 2,4-Diphenylimidazole,

[0082] 2,4-Diphenyl-5-methylimidazole,

[0083] 2,4-Diphenyl-5-hexylimidazole,

[0084] 2-phenyl-4-(2-chlorophenyl)imidazole,

[0085] 2-phenyl-4-(3-chlorophenyl)imidazole,

[0086] 2-phenyl-4-(4-chlorophenyl)imidazole,

[0087] 2-phenyl-4-(4-fluorophenyl)imidazole,

[0088] 2-phenyl-4-(4-bromophenyl)imidazole,

[0089] 2-phenyl-4-(4-iodophenyl)imidazole,

[0090] 2-phenyl-4-(2,3-dichlorophenyl)imidazole,

[0091] 2-phenyl-4-(2,4-dichlorophenyl)imidazole,

[0092] 2-phenyl-4-(2,5-dichlorophenyl)imidazole,

[0093] 2-phenyl-4-(2,6-dichlorophenyl)imidazole,

[0094] 2-phenyl-4-(3,4-dichlorophenyl)imidazole,

[0095] 2-phenyl-4-(3,5-dichlorophenyl)imidazole,

[0096] 2-phenyl-4-(2-propyl-3-chlorophenyl)imidazole,

[0097] 2-phenyl-4-(2-chlorophenyl)-5-methylimidazole,

[0098] 2-phenyl-4-(3-chlorophenyl)-5-methylimidazole,

[0099] 2-phenyl-4-(4-chlorophenyl)-5-methylimidazole,

[0100] 2-phenyl-4-(2,3-dichlorophenyl)-5-methylimidazole,

[0101] 2-phenyl-4-(2,4-dichlorophenyl)-5-methylimidazole,

[0102] 2-phenyl-4-(2,5-dichlorophenyl)-5-methylimidazole,

[0103] 2-phenyl-4-(2,6-dichlorophenyl)-5-methylimidazole,

[0104] 2-phenyl-4-(3,4-dichlorophenyl)-5-methylimidazole,

[0105] 2-phenyl-4-(3,5-dichlorophenyl)-5-methylimidazole,

[0106] 2-phenyl-4-(2,3-dichlorophenyl)-5-propylimidazole,

[0107] 2-phenyl-4-(2,4-dichlorophenyl)-5-undecyl imidazole,

[0108] 2-phenyl-4-(1-naphthyl)imidazole,

[0109] 2-phenyl-4-(2-naphthyl)imidazole,

[0110] 2-phenyl-4-(1-naphthyl)-5-methylimidazole,

[0111] 2-phenyl-4-(2-naphthyl)-5-methylimidazole,

[0112] 2-phenyl-4-(2-thienyl)imidazole,

[0113] 2-phenyl-4-(3-thienyl)imidazole,

[0114] 5-methyl-2-phenyl-4-(2-thienyl)imidazole,

[0115] 5-methyl-2-phenyl-4-(3-thienyl)imidazole,

[0116] 4-(2-Furyl)-2-phenylimidazole,

[0117] 2-(2-methylphenyl)-4-phenylimidazole,

[0118] 2-(3-octylphenyl)-4-phenylimidazole,

[0119] 2-(4-Methylphenyl)-4-phenylimidazole,

[0120] 2-(4-isopropylphenyl)-4-phenylimidazole,

[0121] 2-(4-methylphenyl)-4-phenyl-5-methylimidazole,

[0122] 2-(4-isopropylphenyl)-4-phenyl-5-methylimidazole,

[0123] 2-(4-biphenyl)-4-phenyl-5-methylimidazole,

[0124] 2-(2,4-dimethylphenyl)-4-phenylimidazole,

[0125] 2-(2-chlorophenyl)-4-phenylimidazole,

[0126] 2-(3-chlorophenyl)-4-phenylimidazole,

[0127] 2-(4-chlorophenyl)-4-phenylimidazole,

[0128] 2-(4-Fluorophenyl)-4-phenylimidazole,

[0129] 2-(4-bromophenyl)-4-phenylimidazole,

[0130] 2-(4-iodophenyl)-4-phenylimidazole,

[0131] 2-(2,3-dichlorophenyl)-4-phenylimidazole,

[0132] 2-(2,4-dichlorophenyl)-4-phenylimidazole,

[0133] 2-(2,5-dichlorophenyl)-4-phenylimidazole,

[0134] 2-(2,6-dichlorophenyl)-4-phenylimidazole,

[0135] 2-(3,4-dichlorophenyl)-4-phenylimidazole,

[0136] 2-(3,5-dichlorophenyl)-4-phenylimidazole,

[0137] 2-(2,4-dibromophenyl)-4-phenylimidazole,

[0138] 2-(2-methyl-4-chlorophenyl)-4-phenylimidazole,

[0139] 2-(4-chlorophenyl)-4-phenyl-5-methylimidazole,

[0140] 4-(2,4-dichlorophenyl)-2-(4-methoxyphenyl)-5-methylimidazole,

[0141] 2-(2,3-dichlorophenyl)-4-phenyl-5-methylimidazole,

[0142] 2-(2,4-dichlorophenyl)-4-phenyl-5-methylimidazole,

[0143] 2-(2,5-dichlorophenyl)-4-phenyl-5-methylimidazole,

[0144] 2-(2,6-dichlorophenyl)-4-phenyl-5-methylimidazole,

[0145] 2-(3,4-dichlorophenyl)-4-phenyl-5-methylimidazole,

[0146] 2-(3,5-dichlorophenyl)-4-phenyl-5-methylimidazole,

[0147] 2-(2,4-dichlorophenyl)-4-phenyl-5-ethylimidazole,

[0148] 2-(2,3-dichlorophenyl)-4-phenyl-5-decyl imidazole,

[0149] 2-(3,4-dichlorophenyl)-4-phenyl-5-heptadecylimidazole,

[0150] 2-(2-heptyl-4-chlorophenyl)-4-phenyl-5-isobutylimidazole,

[0151] 2,4-Bis(4-chlorophenyl)imidazole,

[0152] 2-(2,4-dichlorophenyl)-4-(3,4-dichlorophenyl)-5-methylimidazole,

[0153] 4-(2,4-dichlorophenyl)-2-(3,4-dimethoxyphenyl)-5-methylimidazole,

[0154] 4-(3,4-dichlorophenyl)-2-(3,4-dimethoxyphenyl)-5-methylimidazole,

[0155] 2-(4-methylphenyl)-4-(2-naphthyl)imidazole,

[0156] 2-(4-isopropylphenyl)-4-(1-naphthyl)imidazole,

[0157] 2-(3,4-dimethoxyphenyl)-4-(1-naphthyl)imidazole,

[0158] 2-(4-methylphenyl)-4-(4-chloro-6-butyl-1-naphthyl)imidazole, etc.

[0159] Examples of the imidazole compound represented by formula (I-3) include:

[0160] 2-(1-naphthyl)-4-phenylimidazole,

[0161] 2-(2-naphthyl)-4-phenylimidazole,

[0162] 2-(1-naphthyl)-4-phenyl-5-methylimidazole,

[0163] 2-(2-naphthyl)-4-phenyl-5-methylimidazole, etc.

[0164] Examples of the imidazole compound represented by formula (I-4) include:

[0165] 2-Benzyl-4-phenylimidazole,

[0166] 2-Benzyl-4-(4-hexylphenyl)imidazole,

[0167] 2-Benzyl-4-(2-chlorophenyl)imidazole,

[0168] 2-Benzyl-4-(3-chlorophenyl)imidazole,

[0169] 2-Benzyl-4-(4-chlorophenyl)imidazole,

[0170] 2-Benzyl-4-(4-bromophenyl)imidazole,

[0171] 2-Benzyl-4-(2,3-dichlorophenyl)imidazole,

[0172] 2-Benzyl-4-(2,4-dichlorophenyl)imidazole,

[0173] 2-Benzyl-4-(2,5-dichlorophenyl)imidazole,

[0174] 2-Benzyl-4-(2,6-dichlorophenyl)imidazole,

[0175] 2-Benzyl-4-(3,4-dichlorophenyl)imidazole,

[0176] 2-Benzyl-4-(3,5-dichlorophenyl)imidazole,

[0177] 2-Benzyl-4-(2,4,5-trichlorophenyl)imidazole,

[0178] 2-Benzyl-4-(3,4,5-trichlorophenyl)imidazole,

[0179] 2-Benzyl-5-methyl-4-phenylimidazole,

[0180] 2-Benzyl-5-butyl-4-phenylimidazole,

[0181] 2-Benzyl-5-heptyl-4-phenylimidazole,

[0182] 2-Benzyl-5-hexyl-4-phenylimidazole,

[0183] 2-Benzyl-5-octyl-4-phenylimidazole,

[0184] 2-Benzyl-4-(2-chlorophenyl)-5-methylimidazole,

[0185] 2-Benzyl-4-(3-chlorophenyl)-5-methylimidazole,

[0186] 2-Benzyl-4-(4-chlorophenyl)-5-methylimidazole,

[0187] 2-Benzyl-4-(2,4-dichlorophenyl)-5-methylimidazole,

[0188] 2-Benzyl-4-(3,4-dichlorophenyl)-5-methylimidazole,

[0189] 2-Benzyl-5-methyl-4-(2,4,5-trichlorophenyl)imidazole,

[0190] 2-Benzyl-4,5-diphenylimidazole,

[0191] 2-Benzyl-4-(1-naphthyl)imidazole,

[0192] 2-Benzyl-4-(2-naphthyl)imidazole,

[0193] 2-(2-chlorobenzyl)-4-phenylimidazole,

[0194] 2-(3-chlorobenzyl)-4-phenylimidazole,

[0195] 2-(4-chlorobenzyl)-4-phenylimidazole,

[0196] 2-(4-bromobenzyl)-4-phenylimidazole,

[0197] 2-(4-chlorobenzyl)-4-(4-chlorophenyl)imidazole,

[0198] 4-(4-bromophenyl)-2-(4-chlorobenzyl)imidazole,

[0199] 2-(4-bromobenzyl)-4-(4-chlorophenyl)imidazole,

[0200] 2-(4-fluorobenzyl)-4-(4-fluorophenyl)imidazole,

[0201] 2-(2-bromobenzyl)-4-(4-bromophenyl)imidazole,

[0202] 2-(4-bromobenzyl)-4-(3-bromophenyl)imidazole,

[0203] 4-(4-butylphenyl)-2-(2-chlorobenzyl)imidazole,

[0204] 2-(2-chlorobenzyl)-4-(4-hexylphenyl)imidazole,

[0205] 2-(2-chlorobenzyl)-4-(2,4-dichlorophenyl)imidazole,

[0206] 2-(2-chlorobenzyl)-4-(3,4-dichlorophenyl)imidazole,

[0207] 2-(3-chlorobenzyl)-4-(2,4-dichlorophenyl)imidazole,

[0208] 2-(3-chlorobenzyl)-4-(3,4-dichlorophenyl)imidazole,

[0209] 2-(4-chlorobenzyl)-4-(2,4-dichlorophenyl)imidazole,

[0210] 2-(4-chlorobenzyl)-4-(3,4-dichlorophenyl)imidazole,

[0211] 2-(4-chlorobenzyl)-4-(2,4-dibromophenyl)imidazole,

[0212] 4-(2,4-dichlorophenyl)-2-(4-methylbenzyl)-5-methylimidazole,

[0213] 2-(2,3-dichlorobenzyl)-4-phenylimidazole,

[0214] 2-(2,4-dichlorobenzyl)-4-phenylimidazole,

[0215] 2-(2,5-dichlorobenzyl)-4-phenylimidazole,

[0216] 2-(2,6-dichlorobenzyl)-4-phenylimidazole,

[0217] 2-(3,4-dichlorobenzyl)-4-phenylimidazole,

[0218] 2-(3,5-dichlorobenzyl)-4-phenylimidazole,

[0219] 4-(2-chlorophenyl)-2-(2,4-dichlorobenzyl)imidazole,

[0220] 4-(2-chlorophenyl)-2-(3,4-dichlorobenzyl)imidazole,

[0221] 4-(3-chlorophenyl)-2-(2,4-dichlorobenzyl)imidazole,

[0222] 4-(3-chlorophenyl)-2-(3,4-dichlorobenzyl)imidazole,

[0223] 4-(4-chlorophenyl)-2-(2,4-dichlorobenzyl)imidazole,

[0224] 4-(4-chlorophenyl)-2-(3,4-dichlorobenzyl)imidazole,

[0225] 4-(4-bromophenyl)-2-(2,4-dichlorobenzyl)imidazole,

[0226] 4-(4-biphenyl)-2-(2,4-dichlorobenzyl)imidazole,

[0227] 2-(2,3-dichlorobenzyl)-4-(2,4-dichlorophenyl)imidazole,

[0228] 2-(2,4-dichlorobenzyl)-4-(2,4-dichlorophenyl)imidazole,

[0229] 2-(2,5-dichlorobenzyl)-4-(2,4-dichlorophenyl)imidazole,

[0230] 2-(2,6-dichlorobenzyl)-4-(2,4-dichlorophenyl)imidazole,

[0231] 2-(3,4-dichlorobenzyl)-4-(2,4-dichlorophenyl)imidazole,

[0232] 2-(3,5-dichlorobenzyl)-4-(2,4-dichlorophenyl)imidazole,

[0233] 2-(2,3-dichlorobenzyl)-4-(3,4-dichlorophenyl)imidazole,

[0234] 2-(2,4-dichlorobenzyl)-4-(3,4-dichlorophenyl)imidazole,

[0235] 2-(2,5-dichlorobenzyl)-4-(3,4-dichlorophenyl)imidazole,

[0236] 2-(2,6-dichlorobenzyl)-4-(3,4-dichlorophenyl)imidazole,

[0237] 2-(3,4-dichlorobenzyl)-4-(3,4-dichlorophenyl)imidazole,

[0238] 2-(3,5-dichlorobenzyl)-4-(3,4-dichlorophenyl)imidazole,

[0239] 4-phenyl-2-(3,4,5-trichlorobenzyl)imidazole,

[0240] 2-(4-chlorobenzyl)-5-methyl-4-phenylimidazole,

[0241] 2-(4-chlorobenzyl)-4-(4-chlorophenyl)-5-methylimidazole,

[0242] 2-(4-bromobenzyl)-4-(4-bromophenyl)-5-methylimidazole,

[0243] 2-(2-chlorobenzyl)-4-(2,4-dichlorophenyl)-5-methylimidazole,

[0244] 2-(2-chlorobenzyl)-4-(3,4-dichlorophenyl)-5-methylimidazole,

[0245] 2-(3-chlorobenzyl)-4-(2,4-dichlorophenyl)-5-methylimidazole,

[0246] 2-(3-chlorobenzyl)-4-(3,4-dichlorophenyl)-5-methylimidazole,

[0247] 2-(4-chlorobenzyl)-4-(2,4-dichlorophenyl)-5-methylimidazole,

[0248] 2-(4-chlorobenzyl)-4-(3,4-dichlorophenyl)-5-methylimidazole,

[0249] 2-(4-chlorobenzyl)-4-(2,4-dibromophenyl)-5-methylimidazole,

[0250] 4-(2,4-dichlorophenyl)-2-(4-fluorobenzyl)-5-methylimidazole,

[0251] 4-(3,4-dichlorophenyl)-2-(4-fluorobenzyl)-5-methylimidazole,

[0252] 2-(4-bromobenzyl)-4-(2,4-dichlorophenyl)-5-methylimidazole,

[0253] 2-(4-bromobenzyl)-4-(3,4-dichlorophenyl)-5-methylimidazole,

[0254] 2-(2,4-dichlorobenzyl)-5-methyl-4-phenylimidazole,

[0255] 2-(3,4-dichlorobenzyl)-5-methyl-4-phenylimidazole,

[0256] 4-(2-chlorophenyl)-2-(2,4-dichlorobenzyl)-5-methylimidazole,

[0257] 4-(2-chlorophenyl)-2-(3,4-dichlorobenzyl)-5-methylimidazole,

[0258] 4-(3-chlorophenyl)-2-(2,4-dichlorobenzyl)-5-methylimidazole,

[0259] 4-(3-chlorophenyl)-2-(3,4-dichlorobenzyl)-5-methylimidazole,

[0260] 4-(4-chlorophenyl)-2-(2,4-dichlorobenzyl)-5-methylimidazole,

[0261] 4-(4-chlorophenyl)-2-(3,4-dichlorobenzyl)-5-methylimidazole,

[0262] 2-(2,4-dichlorobenzyl)-5-methyl-4-(4-methylphenyl)imidazole,

[0263] 2-(2,4-dichlorobenzyl)-4-(4-methoxyphenyl)-5-methylimidazole,

[0264] 2-(2,3-dichlorobenzyl)-4-(2,4-dichlorophenyl)-5-methylimidazole,

[0265] 2-(2,4-dichlorobenzyl)-4-(2,4-dichlorophenyl)-5-methylimidazole,

[0266] 2-(2,6-dichlorobenzyl)-4-(2,4-dichlorophenyl)-5-methylimidazole,

[0267] 2-(3,4-dichlorobenzyl)-4-(2,4-dichlorophenyl)-5-methylimidazole,

[0268] 2-(2,4-dichlorobenzyl)-4-(3,4-dichlorophenyl)-5-methylimidazole,

[0269] 2-(3,4-dichlorobenzyl)-4-(3,4-dichlorophenyl)-5-methylimidazole,

[0270] 2-(2,4-dibromobenzyl)-4-(3,4-dibromophenyl)-5-methylimidazole,

[0271] 4-(2,4-dichlorophenyl)-2-(3,4-dimethoxybenzyl)-5-methylimidazole,

[0272] 4-(3-chloro-4-methylphenyl)-2-(2,4-dichlorobenzyl)-5-methylimidazole,

[0273] 2-(2-chlorobenzyl)-4,5-diphenylimidazole,

[0274] 2-(3-chlorobenzyl)-4,5-diphenylimidazole,

[0275] 2-(4-chlorobenzyl)-4,5-diphenylimidazole,

[0276] 2-(2,4-dichlorobenzyl)-4,5-diphenylimidazole,

[0277] 2-(2,4-dichlorobenzyl)-5-hexyl-4-phenylimidazole,

[0278] 2-(2-chlorobenzyl)-4-(1-naphthyl)imidazole,

[0279] 2-(2-chlorobenzyl)-4-(2-naphthyl)imidazole,

[0280] 2-(3-chlorobenzyl)-4-(1-naphthyl)imidazole,

[0281] 2-(3-chlorobenzyl)-4-(2-naphthyl)imidazole,

[0282] 2-(4-chlorobenzyl)-4-(1-naphthyl)imidazole,

[0283] 2-(4-chlorobenzyl)-4-(2-naphthyl)imidazole,

[0284] 2-(2,3-dichlorobenzyl)-4-(1-naphthyl)imidazole,

[0285] 2-(2,3-dichlorobenzyl)-4-(2-naphthyl)imidazole,

[0286] 2-(2,4-dichlorobenzyl)-4-(1-naphthyl)imidazole,

[0287] 2-(2,4-dichlorobenzyl)-4-(2-naphthyl)imidazole,

[0288] 2-(2,5-dichlorobenzyl)-4-(1-naphthyl)imidazole,

[0289] 2-(2,5-dichlorobenzyl)-4-(2-naphthyl)imidazole,

[0290] 2-(2,6-dichlorobenzyl)-4-(1-naphthyl)imidazole,

[0291] 2-(2,6-dichlorobenzyl)-4-(2-naphthyl)imidazole,

[0292] 2-(3,4-dichlorobenzyl)-4-(1-naphthyl)imidazole,

[0293] 2-(3,4-dichlorobenzyl)-4-(2-naphthyl)imidazole,

[0294] 2-(3,5-dichlorobenzyl)-4-(1-naphthyl)imidazole,

[0295] 2-(3,5-dichlorobenzyl)-4-(2-naphthyl)imidazole, etc.

[0296] Examples of the imidazole compound represented by formula (I-5) include:

[0297] 2-(1-naphthylmethyl)-4-phenylimidazole,

[0298] 2-(2-naphthylmethyl)-4-phenylimidazole,

[0299] 4-(2-chlorophenyl)-2-(1-naphthylmethyl)imidazole,

[0300] 4-(2-chlorophenyl)-2-(2-naphthylmethyl)imidazole,

[0301] 4-(3-chlorophenyl)-2-(1-naphthylmethyl)imidazole,

[0302] 4-(3-chlorophenyl)-2-(2-naphthylmethyl)imidazole,

[0303] 4-(4-chlorophenyl)-2-(1-naphthylmethyl)imidazole,

[0304] 4-(4-chlorophenyl)-2-(2-naphthylmethyl)imidazole,

[0305] 4-(2,3-dichlorophenyl)-2-(1-naphthylmethyl)imidazole,

[0306] 4-(2,3-dichlorophenyl)-2-(2-naphthylmethyl)imidazole,

[0307] 4-(2,4-dichlorophenyl)-2-(1-naphthylmethyl)imidazole,

[0308] 4-(2,4-dichlorophenyl)-2-(2-naphthylmethyl)imidazole,

[0309] 4-(2,5-dichlorophenyl)-2-(1-naphthylmethyl)imidazole,

[0310] 4-(2,5-dichlorophenyl)-2-(2-naphthylmethyl)imidazole,

[0311] 4-(2,6-dichlorophenyl)-2-(1-naphthylmethyl)imidazole,

[0312] 4-(2,6-dichlorophenyl)-2-(2-naphthylmethyl)imidazole,

[0313] 4-(3,4-dichlorophenyl)-2-(1-naphthylmethyl)imidazole,

[0314] 4-(3,4-dichlorophenyl)-2-(2-naphthylmethyl)imidazole,

[0315] 4-(3,5-dichlorophenyl)-2-(1-naphthylmethyl)imidazole,

[0316] 4-(3,5-dichlorophenyl)-2-(2-naphthylmethyl)imidazole,

[0317] 5-methyl-2-(1-naphthylmethyl)-4-phenylimidazole,

[0318] 5-methyl-2-(2-naphthylmethyl)-4-phenylimidazole,

[0319] 4-(2-chlorophenyl)-5-methyl-2-(1-naphthylmethyl)imidazole,

[0320] 4-(2-chlorophenyl)-5-methyl-2-(2-naphthylmethyl)imidazole,

[0321] 4-(3-chlorophenyl)-5-methyl-2-(1-naphthylmethyl)imidazole,

[0322] 4-(3-chlorophenyl)-5-methyl-2-(2-naphthylmethyl)imidazole,

[0323] 4-(4-chlorophenyl)-5-methyl-2-(1-naphthylmethyl)imidazole,

[0324] 4-(4-chlorophenyl)-5-methyl-2-(2-naphthylmethyl)imidazole,

[0325] 4-(2,3-dichlorophenyl)-5-methyl-2-(1-naphthylmethyl)imidazole,

[0326] 4-(2,3-dichlorophenyl)-5-methyl-2-(2-naphthylmethyl)imidazole,

[0327] 4-(2,4-dichlorophenyl)-5-methyl-2-(1-naphthylmethyl)imidazole,

[0328] 4-(2,4-dichlorophenyl)-5-methyl-2-(2-naphthylmethyl)imidazole,

[0329] 4-(2,5-dichlorophenyl)-5-methyl-2-(1-naphthylmethyl)imidazole,

[0330] 4-(2,5-dichlorophenyl)-5-methyl-2-(2-naphthylmethyl)imidazole,

[0331] 4-(2,6-dichlorophenyl)-5-methyl-2-(1-naphthylmethyl)imidazole,

[0332] 4-(2,6-dichlorophenyl)-5-methyl-2-(2-naphthylmethyl)imidazole,

[0333] 4-(3,4-dichlorophenyl)-5-methyl-2-(1-naphthylmethyl)imidazole,

[0334] 4-(3,4-dichlorophenyl)-5-methyl-2-(2-naphthylmethyl)imidazole,

[0335] 4-(3,5-dichlorophenyl)-5-methyl-2-(1-naphthylmethyl)imidazole,

[0336] 4-(3,5-dichlorophenyl)-5-methyl-2-(2-naphthylmethyl)imidazole, etc.

[0337] Examples of the imidazole compound represented by formula (I-6) include:

[0338] 4-phenyl-2-(2-thienyl)imidazole,

[0339] 4-phenyl-2-(3-thienyl)imidazole,

[0340] 4-(2-chlorophenyl)-2-(2-thienyl)imidazole,

[0341] 4-(2-chlorophenyl)-2-(3-thienyl)imidazole,

[0342] 4-(3-chlorophenyl)-2-(2-thienyl)imidazole,

[0343] 4-(3-chlorophenyl)-2-(3-thienyl)imidazole,

[0344] 4-(4-chlorophenyl)-2-(2-thienyl)imidazole,

[0345] 4-(4-chlorophenyl)-2-(3-thienyl)imidazole,

[0346] 4-(2,3-dichlorophenyl)-2-(2-thienyl)imidazole,

[0347] 4-(2,3-dichlorophenyl)-2-(3-thienyl)imidazole,

[0348] 4-(2,4-dichlorophenyl)-2-(2-thienyl)imidazole,

[0349] 4-(2,4-dichlorophenyl)-2-(3-thienyl)imidazole,

[0350] 4-(2,5-dichlorophenyl)-2-(2-thienyl)imidazole,

[0351] 4-(2,5-dichlorophenyl)-2-(3-thienyl)imidazole,

[0352] 4-(2,6-dichlorophenyl)-2-(2-thienyl)imidazole,

[0353] 4-(2,6-dichlorophenyl)-2-(3-thienyl)imidazole,

[0354] 4-(3,4-dichlorophenyl)-2-(2-thienyl)imidazole,

[0355] 4-(3,4-dichlorophenyl)-2-(3-thienyl)imidazole,

[0356] 4-(3,5-dichlorophenyl)-2-(2-thienyl)imidazole,

[0357] 4-(3,5-dichlorophenyl)-2-(3-thienyl)imidazole,

[0358] 4-(1-naphthyl)-2-(2-thienyl)imidazole,

[0359] 4-(1-naphthyl)-2-(3-thienyl)imidazole,

[0360] 4-(2-naphthyl)-2-(2-thienyl)imidazole,

[0361] 4-(2-naphthyl)-2-(3-thienyl)imidazole,

[0362] 5-methyl-4-phenyl-2-(2-thienyl)imidazole,

[0363] 5-methyl-4-phenyl-2-(3-thienyl)imidazole,

[0364] 4-(2-chlorophenyl)-5-methyl-2-(2-thienyl)imidazole,

[0365] 4-(2-chlorophenyl)-5-methyl-2-(3-thienyl)imidazole,

[0366] 4-(3-chlorophenyl)-5-methyl-2-(2-thienyl)imidazole,

[0367] 4-(3-chlorophenyl)-5-methyl-2-(3-thienyl)imidazole,

[0368] 4-(4-chlorophenyl)-5-methyl-2-(2-thienyl)imidazole,

[0369] 4-(4-chlorophenyl)-5-methyl-2-(3-thienyl)imidazole,

[0370] 4-(2,3-dichlorophenyl)-5-methyl-2-(2-thienyl)imidazole,

[0371] 4-(2,3-dichlorophenyl)-5-methyl-2-(3-thienyl)imidazole,

[0372] 4-(2,4-dichlorophenyl)-5-methyl-2-(2-thienyl)imidazole,

[0373] 4-(2,4-dichlorophenyl)-5-methyl-2-(3-thienyl)imidazole,

[0374] 4-(2,5-dichlorophenyl)-5-methyl-2-(2-thienyl)imidazole,

[0375] 4-(2,5-dichlorophenyl)-5-methyl-2-(3-thienyl)imidazole,

[0376] 4-(2,6-dichlorophenyl)-5-methyl-2-(2-thienyl)imidazole,

[0377] 4-(2,6-dichlorophenyl)-5-methyl-2-(3-thienyl)imidazole,

[0378] 4-(3,4-dichlorophenyl)-5-methyl-2-(2-thienyl)imidazole,

[0379] 4-(3,4-dichlorophenyl)-5-methyl-2-(3-thienyl)imidazole,

[0380] 4-(3,5-dichlorophenyl)-5-methyl-2-(2-thienyl)imidazole,

[0381] 4-(3,5-dichlorophenyl)-5-methyl-2-(3-thienyl)imidazole,

[0382] 5-methyl-4-(1-naphthyl)-2-(2-thienyl)imidazole,

[0383] 5-methyl-4-(1-naphthyl)-2-(3-thienyl)imidazole,

[0384] 5-methyl-4-(2-naphthyl)-2-(2-thienyl)imidazole,

[0385] 5-methyl-4-(2-naphthyl)-2-(3-thienyl)imidazole,

[0386] 4,5-Diphenyl-2-(2-thienyl)imidazole,

[0387] 4,5-diphenyl-2-(3-thienyl)imidazole,

[0388] 4-(2-chlorophenyl)-5-phenyl-2-(2-thienyl)imidazole,

[0389] 4-(2-chlorophenyl)-5-phenyl-2-(3-thienyl)imidazole,

[0390] 4-(3-chlorophenyl)-5-phenyl-2-(2-thienyl)imidazole,

[0391] 4-(3-chlorophenyl)-5-phenyl-2-(3-thienyl)imidazole,

[0392] 4-(4-chlorophenyl)-5-phenyl-2-(2-thienyl)imidazole,

[0393] 4-(4-chlorophenyl)-5-phenyl-2-(3-thienyl)imidazole,

[0394] 4-(2,3-dichlorophenyl)-5-phenyl-2-(2-thienyl)imidazole,

[0395] 4-(2,3-dichlorophenyl)-5-phenyl-2-(3-thienyl)imidazole,

[0396] 4-(2,4-dichlorophenyl)-5-phenyl-2-(2-thienyl)imidazole,

[0397] 4-(2,4-dichlorophenyl)-5-phenyl-2-(3-thienyl)imidazole,

[0398] 4-(2,5-dichlorophenyl)-5-phenyl-2-(2-thienyl)imidazole,

[0399] 4-(2,5-dichlorophenyl)-5-phenyl-2-(3-thienyl)imidazole,

[0400] 4-(2,6-dichlorophenyl)-5-phenyl-2-(2-thienyl)imidazole,

[0401] 4-(2,6-dichlorophenyl)-5-phenyl-2-(3-thienyl)imidazole,

[0402] 4-(3,4-dichlorophenyl)-5-phenyl-2-(2-thienyl)imidazole,

[0403] 4-(3,4-dichlorophenyl)-5-phenyl-2-(3-thienyl)imidazole,

[0404] 4-(3,5-dichlorophenyl)-5-phenyl-2-(2-thienyl)imidazole,

[0405] 4-(3,5-dichlorophenyl)-5-phenyl-2-(3-thienyl)imidazole,

[0406] 4-(1-naphthyl)-5-phenyl-2-(2-thienyl)imidazole,

[0407] 4-(1-naphthyl)-5-phenyl-2-(3-thienyl)imidazole,

[0408] 4-(2-naphthyl)-5-phenyl-2-(2-thienyl)imidazole,

[0409] 4-(2-naphthyl)-5-phenyl-2-(3-thienyl)imidazole, etc.

[0410] In addition, specific examples of the imidazole compound represented by formula (I) include:

[0411] 5-cyclohexyl-2,4-diphenylimidazole,

[0412] 5-cyclohexyl-2-(2,4-dichlorobenzyl)-4-phenylimidazole,

[0413] 2-(3,6-dichloro-2-naphthyl)-4-(2-isopropyl-5-fluorophenyl)-5-decyl imidazole,

[0414] 4-phenyl-2-(2-thienylmethyl)imidazole,

[0415] 4-phenyl-2-(3-thienylmethyl)imidazole,

[0416] 4-(2-chlorophenyl)-2-(2-thienylmethyl)imidazole,

[0417] 4-(2-chlorophenyl)-2-(3-thienylmethyl)imidazole,

[0418] 4-(3-chlorophenyl)-2-(2-thienylmethyl)imidazole,

[0419] 4-(3-chlorophenyl)-2-(3-thienylmethyl)imidazole,

[0420] 4-(4-chlorophenyl)-2-(2-thienylmethyl)imidazole,

[0421] 4-(4-chlorophenyl)-2-(3-thienylmethyl)imidazole,

[0422] 4-(2,3-dichlorophenyl)-2-(2-thienylmethyl)imidazole,

[0423] 4-(2,3-dichlorophenyl)-2-(3-thienylmethyl)imidazole,

[0424] 4-(2,4-dichlorophenyl)-2-(2-thienylmethyl)imidazole,

[0425] 4-(2,4-dichlorophenyl)-2-(3-thienylmethyl)imidazole,

[0426] 4-(2,5-dichlorophenyl)-2-(2-thienylmethyl)imidazole,

[0427] 4-(2,5-dichlorophenyl)-2-(3-thienylmethyl)imidazole,

[0428] 4-(2,6-dichlorophenyl)-2-(2-thienylmethyl)imidazole,

[0429] 4-(2,6-dichlorophenyl)-2-(3-thienylmethyl)imidazole,

[0430] 4-(3,4-dichlorophenyl)-2-(2-thienylmethyl)imidazole,

[0431] 4-(3,4-dichlorophenyl)-2-(3-thienylmethyl)imidazole,

[0432] 4-(3,5-dichlorophenyl)-2-(2-thienylmethyl)imidazole,

[0433] 4-(3,5-dichlorophenyl)-2-(3-thienylmethyl)imidazole,

[0434] 4-(1-naphthyl)-2-(2-thienylmethyl)imidazole,

[0435] 4-(1-naphthyl)-2-(3-thienylmethyl)imidazole,

[0436] 4-(2-naphthyl)-2-(2-thienylmethyl)imidazole,

[0437] 4-(2-naphthyl)-2-(3-thienylmethyl)imidazole,

[0438] 5-methyl-4-phenyl-2-(2-thienylmethyl)imidazole,

[0439] 5-methyl-4-phenyl-2-(3-thienylmethyl)imidazole,

[0440] 4-(2-chlorophenyl)-5-methyl-2-(2-thienylmethyl)imidazole,

[0441] 4-(2-chlorophenyl)-5-methyl-2-(3-thienylmethyl)imidazole,

[0442] 4-(3-chlorophenyl)-5-methyl-2-(2-thienylmethyl)imidazole,

[0443] 4-(3-chlorophenyl)-5-methyl-2-(3-thienylmethyl)imidazole,

[0444] 4-(4-chlorophenyl)-5-methyl-2-(2-thienylmethyl)imidazole,

[0445] 4-(4-chlorophenyl)-5-methyl-2-(3-thienylmethyl)imidazole,

[0446] 4-(2,3-dichlorophenyl)-5-methyl-2-(2-thienylmethyl)imidazole,

[0447] 4-(2,3-dichlorophenyl)-5-methyl-2-(3-thienylmethyl)imidazole,

[0448] 4-(2,4-dichlorophenyl)-5-methyl-2-(2-thienylmethyl)imidazole,

[0449] 4-(2,4-dichlorophenyl)-5-methyl-2-(3-thienylmethyl)imidazole,

[0450] 4-(2,5-dichlorophenyl)-5-methyl-2-(2-thienylmethyl)imidazole,

[0451] 4-(2,5-dichlorophenyl)-5-methyl-2-(3-thienylmethyl)imidazole,

[0452] 4-(2,6-dichlorophenyl)-5-methyl-2-(2-thienylmethyl)imidazole,

[0453] 4-(2,6-dichlorophenyl)-5-methyl-2-(3-thienylmethyl)imidazole,

[0454] 4-(3,4-dichlorophenyl)-5-methyl-2-(2-thienylmethyl)imidazole,

[0455] 4-(3,4-dichlorophenyl)-5-methyl-2-(3-thienylmethyl)imidazole,

[0456] 4-(3,5-dichlorophenyl)-5-methyl-2-(2-thienylmethyl)imidazole,

[0457] 4-(3,5-dichlorophenyl)-5-methyl-2-(3-thienylmethyl)imidazole,

[0458] 5-methyl-4-(1-naphthyl)-2-(2-thienylmethyl)imidazole,

[0459] 5-methyl-4-(1-naphthyl)-2-(3-thienylmethyl)imidazole,

[0460] 5-methyl-4-(2-naphthyl)-2-(2-thienylmethyl)imidazole,

[0461] 5-methyl-4-(2-naphthyl)-2-(3-thienylmethyl)imidazole,

[0462] 4,5-diphenyl-2-(2-thienylmethyl)imidazole,

[0463] 4,5-diphenyl-2-(3-thienylmethyl)imidazole,

[0464] 4-(2-chlorophenyl)-5-phenyl-2-(2-thienylmethyl)imidazole,

[0465] 4-(2-chlorophenyl)-5-phenyl-2-(3-thienylmethyl)imidazole,

[0466] 4-(3-chlorophenyl)-5-phenyl-2-(2-thienylmethyl)imidazole,

[0467] 4-(3-chlorophenyl)-5-phenyl-2-(3-thienylmethyl)imidazole,

[0468] 4-(4-chlorophenyl)-5-phenyl-2-(2-thienylmethyl)imidazole,

[0469] 4-(4-chlorophenyl)-5-phenyl-2-(3-thienylmethyl)imidazole,

[0470] 4-(2,3-dichlorophenyl)-5-phenyl-2-(2-thienylmethyl)imidazole,

[0471] 4-(2,3-dichlorophenyl)-5-phenyl-2-(3-thienylmethyl)imidazole,

[0472] 4-(2,4-dichlorophenyl)-5-phenyl-2-(2-thienylmethyl)imidazole,

[0473] 4-(2,4-dichlorophenyl)-5-phenyl-2-(3-thienylmethyl)imidazole,

[0474] 4-(2,5-dichlorophenyl)-5-phenyl-2-(2-thienylmethyl)imidazole,

[0475] 4-(2,5-dichlorophenyl)-5-phenyl-2-(3-thienylmethyl)imidazole,

[0476] 4-(2,6-dichlorophenyl)-5-phenyl-2-(2-thienylmethyl)imidazole,

[0477] 4-(2,6-dichlorophenyl)-5-phenyl-2-(3-thienylmethyl)imidazole,

[0478] 4-(3,4-dichlorophenyl)-5-phenyl-2-(2-thienylmethyl)imidazole,

[0479] 4-(3,4-dichlorophenyl)-5-phenyl-2-(3-thienylmethyl)imidazole,

[0480] 4-(3,5-dichlorophenyl)-5-phenyl-2-(2-thienylmethyl)imidazole,

[0481] 4-(3,5-dichlorophenyl)-5-phenyl-2-(3-thienylmethyl)imidazole,

[0482] 4-(1-naphthyl)-5-phenyl-2-(2-thienylmethyl)imidazole,

[0483] 4-(1-naphthyl)-5-phenyl-2-(3-thienylmethyl)imidazole,

[0484] 4-(2-naphthyl)-5-phenyl-2-(2-thienylmethyl)imidazole,

[0485] 4-(2-naphthyl)-5-phenyl-2-(3-thienylmethyl)imidazole, etc.

[0486] (Benzimidazole compound represented by formula (II))

[0487] The benzimidazole compound represented by the formula (II) (hereinafter, sometimes referred to as the benzimidazole compound (II)) has the following structure.

[0488]

[0489] (In formula (II),

[0490] R3 represents a linear or branched alkyl group having 1 to 18 carbon atoms, -(CH2) m -Ph, -(CH2) m -Np or a group represented by the following formula (1), Ph represents a phenyl group which may have a substituent, Np represents a naphthyl group which may have a substituent, and m represents an integer of 1 to 5.

[0491]

[0492] (In formula (1), m represents an integer of 1 to 5.)

[0493] R4 are the same or different and represent a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a nitro group or a halogen atom.

[0494] In formula (II), R3 is a linear or branched alkyl group having 1 to 18 carbon atoms, -(CH2) m -Ph (Ph is a phenyl group which may have a substituent, and m is an integer of 1 to 5), -(CH2) m-Np (Np is a naphthyl group which may have a substituent, and m is an integer of 1 to 5) or a group represented by the above formula (1).

[0495] The linear alkyl group and branched alkyl group having 1 to 18 carbon atoms are the same as those described above for the imidazole compound (I).

[0496] In addition, the substituents replacing the hydrogen of the phenyl group and the naphthyl group are also the same as the substituents described in the above-mentioned imidazole compound (I).

[0497] R4 is a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a nitro group, or a halogen atom. The linear or branched alkyl group having 1 to 18 carbon atoms is the same as the alkyl group described in the above-mentioned imidazole compound (I). Examples of the halogen atom include a fluorine atom (F), a chlorine atom (Cl), a bromine atom (Br), an iodine atom (I), and the like. The four R4s may be the same or different.

[0498] From the viewpoint of heat resistance of the chemically generated film, R4 is preferably a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, or a halogen atom, and more preferably a hydrogen atom, a methyl group, or a chlorine atom (Cl).

[0499] As the benzimidazole compound represented by the formula (II) (benzimidazole compound (II)), benzimidazole compounds represented by the formula (II-1) to the formula (II-4) are preferred.

[0500]

[0501] (In formula (II-1), R 312 represents a linear or branched alkyl group having 1 to 18 carbon atoms, R 415 are the same or different and represent a linear or branched alkyl group or a halogen atom having 1 to 18 carbon atoms; and q represents an integer of 0 to 3.

[0502] In the formula (II-2), X is the same or different and represents a halogen atom, m represents an integer of 1-5, and q represents an integer of 0-3.

[0503] In the formula (II-3), X is the same or different and represents a halogen atom, m represents an integer of 1 to 5, q represents an integer of 0 to 3, and r represents an integer of 0 to 3.

[0504] In formula (II-4), X is the same or different and represents a halogen atom, m represents an integer of 1 to 5, and q represents an integer of 0 to 3.

[0505] Specific examples of the benzimidazole compound (II) include the benzimidazole compound represented by the formula (II-1):

[0506] 2-Methylbenzimidazole,

[0507] 2-Ethylbenzimidazole,

[0508] 2-Propylbenzimidazole,

[0509] 2-Butylbenzimidazole,

[0510] 2-tert-Butylbenzimidazole,

[0511] 2-pentylbenzimidazole,

[0512] 2-Hexylbenzimidazole,

[0513] 2-Heptylbenzimidazole,

[0514] 2-Octylbenzimidazole,

[0515] 2-nonylbenzimidazole,

[0516] 2-Decylbenzimidazole,

[0517] 2-Undecylbenzimidazole,

[0518] 2-Dodecylbenzimidazole,

[0519] 2-Tridecylbenzimidazole,

[0520] 2-Tetradecylbenzimidazole,

[0521] 2-pentadecylbenzimidazole,

[0522] 2-Hexadecylbenzimidazole,

[0523] 2-heptadecanylbenzimidazole,

[0524] 2-Heptyl-5,6-dimethylbenzimidazole,

[0525] 2-Octyl-5-chlorobenzimidazole,

[0526] 2-pentyl-5,6-dichlorobenzimidazole, etc.

[0527] Examples of the benzimidazole compound represented by formula (II-2) include:

[0528] 2-(2-Thienylmethyl)benzimidazole,

[0529] 2-(3-Thienylmethyl)benzimidazole, etc.

[0530] Examples of the benzimidazole compound represented by formula (II-3) include:

[0531] 2-(phenylmethyl)benzimidazole,

[0532] 2-(4-chlorophenylmethyl)benzimidazole,

[0533] 2-(2,4-dichlorophenylmethyl)benzimidazole,

[0534] 2-(3,4-dichlorophenylmethyl)benzimidazole,

[0535] 6-Chloro-2-(3,4-dichlorophenylmethyl)benzimidazole,

[0536] 2-(2-phenylethyl)benzimidazole,

[0537] 2-[2-(4-chlorophenyl)ethyl]benzimidazole,

[0538] 2-(3-phenylpropyl)benzimidazole,

[0539] 2-[3-(2-chlorophenyl)propyl]benzimidazole,

[0540] 2-(4-phenylbutyl)benzimidazole,

[0541] 2-[4-(4-chlorophenyl)butyl]benzimidazole,

[0542] 2-(5-phenylpentyl)benzimidazole,

[0543] 2-[4-(2,4-dichlorophenyl)butyl]-4,7-dichlorobenzimidazole, etc.

[0544] Examples of the benzimidazole compound represented by formula (II-4) include:

[0545] 2-(1-naphthylmethyl)benzimidazole,

[0546] 2-(2-naphthylmethyl)benzimidazole,

[0547] 2-[2-(1-naphthyl)ethyl]benzimidazole,

[0548] 2-[2-(2-naphthyl)ethyl]benzimidazole,

[0549] 2-[3-(1-naphthyl)propyl]benzimidazole,

[0550] 2-[3-(2-naphthyl)propyl]benzimidazole,

[0551] 2-[4-(1-naphthyl)butyl]benzimidazole,

[0552] 2-[4-(2-naphthyl)butyl]benzimidazole,

[0553] 2-[5-(1-naphthyl)pentyl]benzimidazole,

[0554] 2-[5-(2-naphthyl)pentyl]benzimidazole, etc.

[0555] Relative to the total amount of the surface treatment agent, the content of the imidazole compound (I) or the benzimidazole compound (II) is preferably 0.01% by weight to 10% by weight, more preferably 0.05% by weight to 5% by weight, and further preferably 0.05% by weight to 1% by weight. When the content of the imidazole compound (I) or the benzimidazole compound (II) is 0.01% by weight or more, a chemically generated coating can be formed with a film thickness that can prevent oxidation of the copper surface. In addition, when the imidazole compound (I) or the benzimidazole compound (II) is 10% by weight or less, the imidazole compound is easily dissolved in the surface treatment agent and can improve the solderability of the copper surface.

[0556] It should be noted that in the practice of the present invention, the imidazole compound selected from the group consisting of the above-mentioned imidazole compound (I) and benzimidazole compound (II) can be used alone or in combination of two or more.

[0557] The imidazole compound (I) and the benzimidazole compound (II) may be used in the form of a suitable acid or salt. Examples of the acid include HCl (hydrochloric acid) and HBr (hydrogen bromide), and the imidazole compound (I) and the benzimidazole compound (II) may be used in the form of an HCl salt or an HBr salt.

[0558] In the surface treating agent of the present invention, these imidazole compounds (I) and benzimidazole compounds (II) may be used in combination with a known imidazole compound in the same technical field as the present invention.

[0559] (Triazole compound represented by formula (III))

[0560] The triazole compound represented by the formula (III) (hereinafter, sometimes referred to as a triazole compound (III)) has the following structure.

[0561]

[0562] (In formula (III),

[0563] R5 and R6 are the same or different and represent a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, an amino group, a phenyl group which may have a substituent, a benzyl group, a naphthyl group, a pyridyl group which may have a substituent, or a group represented by the following formula (2). However, the case where R5 and R6 are both groups represented by the following formula (2) is excluded.

[0564]

[0565] (In formula (2), t represents an integer from 0 to 12.)

[0566] R7 represents a hydrogen atom, a benzyl group or -(CH2) n -COOH, n represents an integer of 1 to 5. )

[0567] In formula (III), R5 and R6 are a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, an amino group, a phenyl group which may have a substituent, a benzyl group, a naphthyl group, a pyridyl group which may have a substituent, or a group represented by formula (2). R5 and R6 may be the same or different, and they may not simultaneously be a group represented by formula (2).

[0568] The linear alkyl group and branched alkyl group having 1 to 18 carbon atoms are the same as those described above for the imidazole compound (I).

[0569] The substituents replacing the hydrogen atoms of the phenyl group and the benzyl group are the same as those described above for the imidazole compound (I).

[0570] From the viewpoint of heat resistance of the chemically generated film, R5 and R6 are preferably a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, an amino group, a phenyl group which may have a substituent, a benzyl group having a substituent, a naphthyl group, a pyridyl group, or a group represented by formula (2). In formula (2), t is preferably an integer of 0 to 10, more preferably an integer of 0 to 8, and even more preferably 0 to 6.

[0571] R7 represents a hydrogen atom, a benzyl group or -(CH2) n -COOH (n is an integer of 1 to 5).

[0572] From the viewpoint of heat resistance of the chemically generated film, R7 is preferably a hydrogen atom, -(CH2) n -COOH (n is an integer of 1 to 3).

[0573] As the triazole compound represented by the formula (III) (triazole compound (III)), triazole compounds represented by formula (III-1) to formula (III-5) are preferred.

[0574]

[0575] (In formula (III-1), R 513 represents a hydrogen atom, an amino group or a phenyl group which may have a substituent, R 515 represents a hydrogen atom, an amino group or a phenyl group which may have a substituent, and s represents an integer of 1 to 3.

[0576] In formula (III-2), R 523 represents a linear or branched alkyl group or a pyridyl group having 1 to 18 carbon atoms, R 525It represents a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a phenyl group which may have a substituent, a benzyl group or a pyridyl group which may have a substituent.

[0577] In formula (III-3), R 531 represents a hydrogen atom or a benzyl group which may have a substituent, R 535 It represents a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a phenyl group, a naphthyl group or an amino group which may have a substituent.

[0578] In formula (III-4), R 545 It represents a hydrogen atom, a phenyl group which may have a substituent, or a benzyl group which may have a substituent.

[0579] In formula (III-5), t represents an integer of 0 to 6.

[0580] Specific examples of the triazole compound (III) include the triazole compound represented by the formula (III-1):

[0581] 1,2,4-Triazole-1-acetic acid,

[0582] 1,2,4-Triazole-1-propionic acid,

[0583] 1,2,4-Triazole-1-butyric acid,

[0584] 3-amino-1,2,4-triazole-1-acetic acid,

[0585] 3-amino-5-phenyl-1,2,4-triazole-1-acetic acid, etc.

[0586] Examples of the triazole compound represented by formula (III-2) include:

[0587] 3-Methyl-1,2,4-triazole,

[0588] 3-ethyl-1,2,4-triazole,

[0589] 3-propyl-1,2,4-triazole,

[0590] 3-isopropyl-1,2,4-triazole,

[0591] 3-Butyl-1,2,4-triazole,

[0592] 3-pentyl-1,2,4-triazole,

[0593] 3-Hexyl-1,2,4-triazole,

[0594] 3-Octyl-1,2,4-triazole,

[0595] 3-Undecyl-1,2,4-triazole,

[0596] 3,5-dimethyl-1,2,4-triazole,

[0597] 3-ethyl-5-methyl-1,2,4-triazole,

[0598] 3-Methyl-5-propyl-1,2,4-triazole,

[0599] 3-isopropyl-5-methyl-1,2,4-triazole,

[0600] 3-Butyl-5-methyl-1,2,4-triazole,

[0601] 3-Methyl-5-pentyl-1,2,4-triazole,

[0602] 5-heptyl-3-methyl-1,2,4-triazole,

[0603] 5-methyl-3-octyl-1,2,4-triazole,

[0604] 3-Methyl-5-undecyl-1,2,4-triazole,

[0605] 3,5-diethyl-1,2,4-triazole,

[0606] 3,5-dipropyl-1,2,4-triazole,

[0607] 3,5-diisopropyl-1,2,4-triazole,

[0608] 3,5-dibutyl-1,2,4-triazole,

[0609] 3,5-dipentyl-1,2,4-triazole,

[0610] 3,5-Diheptyl-1,2,4-triazole,

[0611] 3,5-Dioctyl-1,2,4-triazole,

[0612] 3,5-diundecyl-1,2,4-triazole,

[0613] 3-Methyl-5-phenyl-1,2,4-triazole,

[0614] 3-ethyl-5-phenyl-1,2,4-triazole,

[0615] 5-phenyl-3-propyl-1,2,4-triazole,

[0616] 3-Butyl-5-phenyl-1,2,4-triazole,

[0617] 3-pentyl-5-phenyl-1,2,4-triazole,

[0618] 3-Methyl-5-(phenylmethyl)-1,2,4-triazole,

[0619] 3-ethyl-5-(phenylmethyl)-1,2,4-triazole,

[0620] 5-(phenylmethyl)-3-propyl-1,2,4-triazole,

[0621] 3-methyl-5-(4-pyridyl)-1,2,4-triazole,

[0622] 3,5-Bis(4-pyridyl)-1,2,4-triazole, etc.

[0623] Examples of the triazole compound represented by formula (III-3) include:

[0624] 3-amino-1,2,4-triazole,

[0625] 3,5-diamino-1,2,4-triazole,

[0626] 3-amino-5-methyl-1,2,4-triazole,

[0627] 3-amino-5-ethyl-1,2,4-triazole,

[0628] 3-amino-5-propyl-1,2,4-triazole,

[0629] 3-amino-5-isopropyl-1,2,4-triazole,

[0630] 3-amino-5-butyl-1,2,4-triazole,

[0631] 3-amino-5-pentyl-1,2,4-triazole,

[0632] 3-amino-5-phenyl-1,2,4-triazole,

[0633] 3-amino-5-(1-naphthyl)-1,2,4-triazole,

[0634] 3-amino-5-(2-naphthyl)-1,2,4-triazole,

[0635] 1-Benzyl-3,5-diamino-1,2,4-triazole, etc.

[0636] Examples of the triazole compound represented by formula (III-4) include:

[0637] 3-phenyl-1,2,4-triazole,

[0638] 3-Benzyl-5-phenyl-1,2,4-triazole,

[0639] 3,5-Diphenyl-1,2,4-triazole, etc.

[0640] Examples of the triazole compound represented by formula (III-5) include:

[0641] 3,3'-bis(5-amino-1,2,4-triazole),

[0642] 3,3'-Methylenebis(5-amino-1,2,4-triazole),

[0643] 3,3'-ethylenebis(5-amino-1,2,4-triazole),

[0644] 3,3'-trimethylenebis(5-amino-1,2,4-triazole),

[0645] 3,3'-Tetramethylenebis(5-amino-1,2,4-triazole),

[0646] 3,3'-pentamethylenebis(5-amino-1,2,4-triazole),

[0647] 3,3'-hexamethylenebis(5-amino-1,2,4-triazole), etc.

[0648] The triazole compound (III) is contained in a ratio of preferably 0.005 to 1% by weight, more preferably 0.01 to 0.5% by weight, and even more preferably 0.01 to 0.3% by weight, based on the total amount of the surface treatment agent.

[0649] It should be noted that in the practice of the present invention, one or more triazole compounds selected from the above triazole compounds (III) may be used in combination, or the triazole compound may be used together with a known triazole compound in the same technical field as the present invention.

[0650] In the present invention, the triazole compound (III) is preferably contained in a molar ratio of 0.005 to 3.0 relative to the imidazole compound (I) or the benzimidazole compound (II), more preferably in a molar ratio of 0.01 to 2.7, and further preferably in a molar ratio of 0.05 to 2.5. When the ratio of the triazole compound (III) to the imidazole compound (I) or the benzimidazole compound (II) is within the above range, a chemically generated film having high heat resistance can be formed.

[0651] The surface treatment agent of the present invention is prepared by dissolving the imidazole compound (I) or the benzimidazole compound (II) and the triazole compound (III) in water, thereby obtaining a water-soluble preflux.

[0652] The water is not particularly limited, and examples thereof include purified water (tap water), ion-exchanged water, purified water, and pure water.

[0653] In order to make the imidazole compound (I) or the benzimidazole compound (II) and the triazole compound (III) easily dissolve in water (convert to aqueous solution), the surface treatment agent of the present invention preferably contains a solubilizer. As the solubilizer, for example, an organic acid or an inorganic acid (these may be referred to as an acid) is preferably used.

[0654] Representative organic acids include formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, heptanoic acid, octanoic acid, nonanoic acid, capric acid, lauric acid, isobutyric acid, 2-ethylbutyric acid, oleic acid, glycolic acid, lactic acid, 2-hydroxybutyric acid, 3-hydroxybutyric acid, gluconic acid, glyceric acid, tartaric acid, malic acid, citric acid, chloroacetic acid, dichloroacetic acid, trichloroacetic acid, bromoacetic acid, iodoacetic acid, methoxyacetic acid, ethoxyacetic acid, propoxyacetic acid, butoxyacetic acid, 2-(2-methoxyethoxy)acetic acid, 2-[2-(2-ethoxyethoxy)acetic acid]

[0063] acetic acid, 2-{2-[2-(2-ethoxyethoxy)ethoxy]ethoxy}acetic acid, 3-methoxypropionic acid, 3-ethoxypropionic acid, 3-propoxypropionic acid, 3-butoxypropionic acid, levulinic acid, glyoxylic acid, pyruvic acid, acetoacetic acid, acrylic acid, crotonic acid, oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, maleic acid, fumaric acid, benzoic acid, p-nitrobenzoic acid, picric acid, salicylic acid, p-toluenesulfonic acid, methanesulfonic acid, aminosulfonic acid, etc., and examples of the inorganic acid include hydrochloric acid, phosphoric acid, sulfuric acid, nitric acid, etc. These acids may be used alone or in combination of two or more.

[0655] The solubilizer is preferably contained in a ratio of 0.1 wt % to 50 wt %, more preferably 0.1 wt % to 40 wt % relative to the total amount of the surface treatment agent. When the ratio of the solubilizer is within the above range, the imidazole compound (I) or the benzimidazole compound (II) and the triazole compound (III) are easily dissolved in water and a chemically generated film is easily formed.

[0656] In the practice of the present invention, the above-mentioned solubilizing agent may be used together with an organic solvent.

[0657] As the organic solvent, for example, preferably used are alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol, ethylene glycol, tetrahydrofurfuryl alcohol; cellosolves such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether; or solvents that are freely miscible with water such as acetone, N,N-dimethylformamide, acetylacetone, etc.

[0658] These organic solvents may be used alone or in combination of two or more.

[0659] The organic solvent is contained in a ratio of preferably 0.1% by weight to 50% by weight, more preferably 1% by weight to 40% by weight, based on the total amount of the surface treatment agent.

[0660] In order to further improve the formation speed (film-forming property) of the chemically generated film and the heat resistance of the film, it is preferred that the surface treatment agent of the present invention contains halide ions. As halide ions, fluoride ions, chloride ions, bromide ions, iodide ions, etc. can be listed, and one type can be included alone or two or more types can be included. Among them, from the viewpoint of improving the heat resistance of the chemically generated film, it is more preferred that the surface treatment agent contains chloride ions.

[0661] The halide ions are preferably contained in a ratio of 0.005% by weight to 1% by weight, and more preferably in a ratio of 0.01% by weight to 0.1% by weight, based on the total amount of the surface treatment agent.

[0662] The halide ions can be contained by adding a halogen compound to the surface treatment agent. Examples of the halogen compound include sodium fluoride, potassium fluoride, ammonium fluoride, sodium chloride, potassium chloride, ammonium chloride, chloropropionic acid, sodium bromide, potassium bromide, ammonium bromide, bromopropionic acid, sodium iodide, potassium iodide, ammonium iodopropionic acid, and the like. One of the halogen compounds may be used alone or in combination of two or more thereof.

[0663] In order to further improve the heat resistance of the formed chemical conversion coating, it is preferred that the surface treatment agent of the present invention contain zinc ions.

[0664] The zinc ions are preferably contained in a ratio of 0.05% by weight to 2% by weight, and more preferably contained in a ratio of 0.1% by weight to 1% by weight.

[0665] Zinc ions can be contained by adding a zinc compound as an auxiliary agent to the surface treatment agent. Examples of the zinc compound include zinc oxide, zinc formate, zinc acetate, zinc oxalate, zinc lactate, zinc citrate, zinc sulfate, zinc nitrate, zinc phosphate, zinc chloride, zinc bromide, zinc iodide, etc., and one type can be used alone or in combination of two or more types.

[0666] In order to increase the formation rate (film-forming property) of the chemical conversion coating on the copper surface, it is preferred that the surface treatment agent of the present invention contain copper ions.

[0667] The copper ions are preferably contained in a ratio of 0.005% by weight to 1% by weight, and more preferably in a ratio of 0.01% by weight to 0.1% by weight, based on the total amount of the surface treatment agent.

[0668] Copper ions can be contained by adding a copper compound as an auxiliary agent to the surface treatment agent. Examples of the copper compound include copper formate, copper acetate, copper oxalate, cuprous chloride, cupric chloride, cupric bromide, cupric bromide, cuprous iodide, copper hydroxide, copper phosphate, copper sulfate, copper nitrate, etc., and one of them can be used alone or in combination of two or more.

[0669] In addition to the aforementioned halogen compounds, zinc compounds, and copper compounds, the surface treatment agent of the present invention may also include metal compounds such as manganese compounds, cobalt compounds, and nickel compounds; and coordination compounds such as crown ethers, bipyridine, porphyrin, and phenanthroline as auxiliary agents for the purpose of improving the film-forming properties of the chemically generated coating and improving the physical properties of the chemically generated coating.

[0670] It should be noted that, as the manganese compound, for example, manganese formate, manganese chloride, manganese oxalate, manganese sulfate, manganese carbonate, etc. can be listed, as the cobalt compound, for example, cobalt acetate, cobalt sulfate, cobalt nitrate, etc. can be listed, as the nickel compound, for example, nickel chloride, nickel acetate, nickel nitrate, nickel carbonate, nickel sulfate, etc. can be listed.

[0671] These metal compounds may be used alone or in combination of two or more, preferably in a ratio of 0.05% to 2% by weight, more preferably in a ratio of 0.1% to 1% by weight, relative to the total amount of the surface treatment agent. In addition, the coordination compound may be used alone or in combination of two or more, preferably in a ratio of 0.05% to 2% by weight, more preferably in a ratio of 0.1% to 1% by weight, relative to the total amount of the surface treatment agent.

[0672] In order to inhibit the formation of a chemical conversion film on the surface of gold (Au) and improve the film-forming properties of the chemical conversion film on the surface of copper, the surface treatment agent of the present invention may contain a chelating agent and / or an iron compound as an auxiliary agent (refer to Japanese Patent Application Laid-Open No. 9-291372. It is included in this specification by reference).

[0673] Examples of the chelating agent include iminodiacetic acid, nitrilotriacetic acid, ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic acid, triethylenetetraaminehexaacetic acid, 1,2-diaminocyclohexanetetraacetic acid, ethylene glycol ether diaminetetraacetic acid, N,N-bis(2-hydroxybenzyl)ethylenediaminediacetic acid, ethylenediaminedipropionic acid, ethylenediaminediacetic acid, diaminopropanoltetraacetic acid, hexamethylenediaminetetraacetic acid, hydroxyethyliminodiacetic acid, diaminopropanetetraacetic acid, nitrilotripropionic acid, ethylenediamine-N,N'-disuccinic acid, ethylenediaminetetramethylenephosphonic acid, nitrilotrimethylenephosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid, and salts thereof.

[0674] The chelating agent is preferably contained in a ratio of 0.01% by weight to 0.4% by weight.

[0675] From the viewpoint of the film-forming property (formation speed) of the chemically generated film, the pH of the surface treatment agent of the present invention is preferably 2.0 to 5.0, more preferably 2.2 to 4.8, and even more preferably 2.5 to 4.5.

[0676] It should be noted that, when the pH of the surface treatment agent is to be lowered, the aforementioned organic acid or inorganic acid can be used, and when the pH is to be increased, a base can be used. As the base, in addition to sodium hydroxide and potassium hydroxide, ammonia or amines such as monoethanolamine, diethanolamine, triethanolamine, and triisopropanolamine can also be listed. As the base, substances having a buffering effect such as amines can be preferably used.

[0677] By bringing the surface treatment agent of the present invention into contact with the surface of copper, a chemical conversion coating can be formed on the surface of copper.

[0678] As conditions for treating the surface of copper using the surface treatment agent of the present invention, it is preferred that the liquid temperature of the surface treatment agent be set within a range of 10° C. to 70° C., and the contact time be set within a range of 1 second to 10 minutes. As a method for contacting copper with the surface treatment agent for treating the surface of copper, methods such as immersion, spraying, and coating can be cited.

[0679] Preferably, after the surface treatment agent is brought into contact with the surface of the copper, it is washed with water as needed, and then the surface of the copper is dried. Drying is preferably set to be carried out at a temperature of room temperature (e.g., 20°C) to 150°C, preferably at a temperature of 60°C to 120°C for 1 second to 10 minutes, preferably about 10 seconds to about 3 minutes. It should be noted that as water for washing with water, pure water such as ion exchange water, distilled water, purified water, etc. is preferred. There is no particular restriction on the method and time of washing with water, and washing with water for an appropriate time can be carried out by a spray method, an immersion method, etc.

[0680] Before the surface treatment agent is brought into contact with the copper surface, a pre-dip solution containing an azole compound may be brought into contact with the copper surface. The pre-dip solution has a function of improving the film-forming property of the chemical conversion film formed on the copper surface.

[0681] The azole compound is not particularly limited, and examples thereof include commercially available imidazole compounds, triazole compounds, tetrazole compounds, and the like.

[0682] The pre-dip solution contains water and additives in addition to the azole compound. The additives may include the aforementioned organic solvents, amines, copper compounds, halogen compounds, and other additives (such as ammonium sulfate, ammonium formate, ammonium acetate, ammonium chloride, ammonium carbonate, ammonium nitrate, and other ammonium salts).

[0683] The thickness of the chemically generated coating (OSP film) formed by the surface treatment agent of the present invention is preferably 0.10 μm to 0.50 μm. When the thickness of the coating is 0.10 μm or more, sufficient heat resistance can be imparted, so the desired effect of the present invention can be obtained. In addition, when the thickness of the coating is 0.50 μm or less, good weldability can be maintained.

[0684] As the solder used in the implementation of the present invention, in addition to the previously known Sn-Pb eutectic solder, lead-free solders such as Sn-Ag-Cu, Sn-Ag-Bi, Sn-Bi, Sn-Ag-Bi-In, Sn-Zn, and Sn-Cu can also be listed.

[0685] In addition, the soldering method of the present invention can be applied to a flow method, a reflow method, and the like. The flow method is to move a printed wiring board mounted with electronic components while in contact with the liquid surface of molten solder in a solder tank, thereby soldering the joints between the electronic components and the printed wiring board. The reflow method is to pre-print a paste-like solder paste on the printed wiring board in accordance with a circuit pattern, mount electronic components thereon, and heat the printed wiring board to melt the solder, thereby performing soldering.

[0686] Example

[0687] Hereinafter, the present invention will be specifically described by way of Examples and Comparative Examples, but the present invention is not limited thereto.

[0688] [Imidazole compounds]

[0689] The imidazole compounds used in the examples are as follows.

[0690] (Synthesis example 1)

[0691] <Synthesis of 4-(3,4-dichlorophenyl)-5-methyl-2-nonylimidazole (A-1)>

[0692] An imidazole compound “4-(3,4-dichlorophenyl)-5-methyl-2-nonylimidazole” (sometimes abbreviated as “A-1”) was synthesized according to the method described in JP-A-2010-77071.

[0693] (Synthesis example 2)

[0694] <Synthesis of 2-phenyl-4-(1-naphthyl)-5-methylimidazole (A-2)>

[0695] An imidazole compound "2-phenyl-4-(1-naphthyl)-5-methylimidazole" (sometimes abbreviated as "A-2") was synthesized according to the method described in Japanese Patent Application Laid-Open No. 2006-36683.

[0696] (Synthesis example 3)

[0697] <Synthesis of 5-methyl-4-phenyl-2-(2-thienyl)imidazole (A-3)>

[0698] An imidazole compound “5-methyl-4-phenyl-2-(2-thienyl)imidazole” (sometimes abbreviated as “A-3”) was synthesized according to the method described in JP-A-2014-37370.

[0699] (Synthesis Example 4)

[0700] <Synthesis of 2-(3-chlorobenzyl)-4-(1-naphthyl)imidazole (A-4)>

[0701] An imidazole compound “2-(3-chlorobenzyl)-4-(1-naphthyl)imidazole” (sometimes abbreviated as “A-4”) was synthesized according to the method described in Japanese Patent Application Laid-Open No. 2010-90105.

[0702] The chemical formulas of the imidazole compounds A-1 to A-4 are shown below.

[0703]

[0704] [Benzimidazole compounds]

[0705] The benzimidazole compounds used in the examples are shown below.

[0706] (Synthesis Example 5)

[0707] <Synthesis of 2-nonylbenzimidazole (B-1)>

[0708] The benzimidazole compound "2-nonylbenzimidazole" (sometimes abbreviated as "B-1") was synthesized according to the method described in Japanese Patent Application Laid-Open No. 5-107814.

[0709] (Synthesis Example 6)

[0710] <Synthesis of 6-chloro-2-(3,4-dichlorophenylmethyl)benzimidazole (B-2)>

[0711] The benzimidazole compound "6-chloro-2-(3,4-dichlorophenylmethyl)benzimidazole" (sometimes abbreviated as "B-2") was synthesized by the following method.

[0712] 133.0 g (0.715 mol) of 3,4-dichlorobenzyl cyanide and 190 g of dehydrated dichloromethane were mixed, and 36.4 g (0.790 mol) of anhydrous ethanol was further added. While stirring under ice cooling, 29.6 g (0.812 mol) of hydrogen chloride gas was blown in little by little, and then stirred at 5°C or below overnight. The obtained product was concentrated under reduced pressure to obtain 192.1 g (0.715 mol, yield 100%) of 2-(3,4-dichlorophenyl)ethylimidate hydrochloride in the form of a white powder.

[0713] 25.4g (0.178 mol) of 4-chloro-1,2-phenylenediamine was mixed with 200mL of anhydrous methanol, and then 48.0g (0.179 mol) of 2-(3,4-dichlorophenyl)ethylimidate hydrochloride was added. Stirring was continued for 2 hours under reflux, and then 23.6g of 25% ammonia water was further added. Then, the mixture was concentrated under reduced pressure to obtain 76.4g of a dark brown tar-like product. The product was stirred in hot water, the obtained solid was hot filtered, and then crushed in a mortar, 400mL of water was added and heated, and then cooled, crystallized, and filtered to obtain black purple crystals. Methanol and activated carbon were added, heated and stirred, the filtrate obtained by filtration was concentrated under reduced pressure, and the obtained product was recrystallized using acetonitrile to obtain 33.7g (0.108 mol, yield 60.9%) of milky white powder 6-chloro-2-(3,4-dichlorophenylmethyl)benzimidazole.

[0714] (Synthesis Example 7)

[0715] <Synthesis of 2-(2-naphthylmethyl)benzimidazole (B-3)>

[0716] The benzimidazole compound "2-(2-naphthylmethyl)benzimidazole" (sometimes abbreviated as "B-3") was synthesized by the following method.

[0717] 50.9g (0.273 mole) of 2-naphthylacetic acid was mixed with 29.5g (0.273 mole) of o-phenylenediamine, and heated until no water flowed out, thereby obtaining a purple solid. The obtained solid was powdered using a mortar, and then 1L of water and 88g of sodium carbonate were added, and stirred under reflux for 30 minutes. After hot filtration, the obtained solid was subjected to the same operation again. Methanol and activated carbon were added thereto, heated and stirred, filtered, and a filtrate was obtained. Water as a poor solvent was added little by little to the obtained filtrate and crystallized. The obtained crystals were cleaned using methanol and water, and then dried, thereby obtaining 39.4g (0.153 mole, a yield of 55.8%) of light yellow crystals of 2-(2-naphthylmethyl)benzimidazole.

[0718] The chemical formulas of the benzimidazole compounds B-1 to B-3 are shown below.

[0719]

[0720] [Triazole compounds]

[0721] The triazole compounds used in the examples are shown below.

[0722] (Synthesis Example 8)

[0723] <Synthesis of 3-amino-1,2,4-triazole-1-acetic acid (C-1)>

[0724] A triazole compound "3-amino-1,2,4-triazole-1-acetic acid" (sometimes abbreviated as "C-1") was synthesized by the following method.

[0725] 30.1g (0.357 mole) of 3-amino-1,2,4-triazole and 200mL of methanol were mixed, and a sodium hydroxide aqueous solution obtained by premixing 14.5g (0.363 mole) of sodium hydroxide and 80.0g of water was added little by little. Then, 41.6g (0.357 mole) of sodium monochloroacetate was added and heated, and stirred under reflux for one night. The obtained product was concentrated under reduced pressure, and then 100mL of water was added, and 36.1g of 36% hydrochloric acid was added little by little while cooling. The precipitate was filtered, then washed with water and dried, thereby obtaining 24.3g (0.171 mole, yield 47.8%) of 3-amino-1,2,4-triazole-1-acetic acid as a white powder.

[0726] (Synthesis Example 9)

[0727] <Synthesis of 5-methyl-3-octyl-1,2,4-triazole (C-2)>

[0728] A triazole compound "5-methyl-3-octyl-1,2,4-triazole" (sometimes abbreviated as "C-2") was synthesized by the following method.

[0729] 37.26 g (0.200 mole) of ethyl nonanoate was mixed with 100 g of methanol, and then 20.02 g (0.400 mole) of hydrazine monohydrate was further added at room temperature, stirred for 1 hour, then heated, and stirred under reflux overnight. The precipitated crystals were filtered by cooling, washed with a small amount of methanol, and then dried to obtain 28.26 g (0.164 mole, yield 82.0%) of nonanoic acid hydrazide as white flaky crystals.

[0730] 15.60g (0.165 mol) of acetamidine hydrochloride was mixed with 100g of methanol, and then 34.72g (0.180 mol) of 28% sodium methoxide / methanol solution was added, and 25.84g (0.150 mol) of nonanoic acid hydrazide was further added. Stirred under reflux for one night, then cooled and filtered to remove NaCl, and then the filtrate was concentrated under reduced pressure. 80g of toluene and 80g of water were added to the obtained concentrate, the product was dissolved in toluene, the organic layer was separated, and then concentrated under reduced pressure to a total amount of 40g. The concentrate was cooled and crystallized, then filtered and dried to obtain 20.51g (0.105 mol, yield 70.0%) of 5-methyl-3-octyl-1,2,4-triazole as a white powder.

[0731] (Synthesis Example 10)

[0732] <Synthesis of 3-benzyl-5-phenyl-1,2,4-triazole (C-3)>

[0733] A triazole compound "3-benzyl-5-phenyl-1,2,4-triazole" (sometimes abbreviated as "C-3") was synthesized by the following method.

[0734] 31.3g (0.200 mole) of benzamidine hydrochloride was mixed with 300mL of ethanol, and then a liquid obtained by mixing 240mL of ethanol with 14.0g (0.259 mole) of sodium methoxide was added. The precipitated NaCl was filtered and removed, and then 30.0g (0.200 mole) of phenylacetic acid hydrazide was added to the obtained filtrate. Stirred for 1 hour under reflux, and then the reaction solution was concentrated under reduced pressure to obtain 55.1g of tarry product. The solid obtained by adding water and stirring was filtered, dried once, and then recrystallized and dried using diethyl ether to obtain 14.4g (0.061 mole, yield 30.6%) of white powder 3-benzyl-5-phenyl-1,2,4-triazole.

[0735] (Synthesis Example 11)

[0736] <Synthesis of 3,3'-methylenebis(5-amino-1,2,4-triazole) (C-4)>

[0737] The triazole compound "3,3'-methylenebis(5-amino-1,2,4-triazole)" (sometimes abbreviated as "C-4") was synthesized according to the method described in Russ. J. Applied Chem., 82(2), 276(2009).

[0738] The chemical formulas of the triazole compounds of C-1 to C-4 are shown below.

[0739]

[0740] The evaluation test methods used in Examples and Comparative Examples are as follows.

[0741] [Evaluation test of solder rise rate]

[0742] As a test piece, a glass epoxy resin printed wiring board of 120 mm (length) × 150 mm (width) × 1.6 mm (thickness) having 300 copper through holes of inner diameters of 0.60 mm, 0.80 mm, and 1.00 mm was used. The test piece was soft-etched, washed with water, and dried under the following conditions, then immersed in a pre-dip solution maintained at a predetermined liquid temperature for a predetermined time, washed with water, and dried, then immersed in a surface treatment agent maintained at a predetermined liquid temperature for a predetermined time, and then surface treated by washing with water and drying, thereby forming a chemically generated film with a thickness of about 0.2 μm on the copper surface.

[0743] The surface treated test pieces were reflow heated using an infrared hot air reflow soldering device (product name: SNR-725GT-MH, manufactured by Senju Metal Industries, Ltd.) under the conditions described in Tables 1 to 6, and then soldered using a flow soldering device (conveyor speed: 1.0 m / min).

[0744] The solder used was "ECO SOLDER M705" (trade name, Sn-3.0Ag-0.5Cu lead-free solder) manufactured by Senju Metal Industries Co., Ltd., and the flux used for soldering was "ES-1062V-1" (trade name) manufactured by Senju Metal Industries Co., Ltd. The soldering temperature was set to 250°C.

[0745] For the soldered test pieces, the number of through holes (soldered) where solder rose to the upper land portion of the copper through hole was measured, and the ratio (%) to the total number of through holes (900 holes) (solder rise rate) was calculated.

[0746] The greater the wettability of the solder to the copper surface, the easier it is for the molten solder to penetrate into the copper through-hole and rise to the upper pad portion of the through-hole. That is, the greater the ratio of the number of through-holes where the solder rises to the upper pad portion relative to the total number of through-holes, the better the solder wettability to copper is judged to be, and the better the weldability is.

[0747] [Surface treatment of test piece]

[0748] The test piece was processed according to the following steps i to iii.

[0749] i. Acid washing / 1 minute (room temperature), water washing, drying / 1 minute (100℃)

[0750] ii. Immerse in pre-dip solution (manufactured by Shikoku Chemical Industry Co., Ltd., "PT20") for 30 seconds (30°C), rinse with water, and dry for 1 minute (100°C)

[0751] iii. Immerse in the surface treatment solution for 1 minute (40°C), rinse with water, and dry for 1 minute (100°C)

[0752] (Example 1)

[0753] 2-(3-chlorobenzyl)-4-(1-naphthyl)imidazole (A-4), 3-amino-1,2,4-triazole-1-acetic acid (C-1), acetic acid and heptanoic acid were dissolved in ion exchange water, and then the pH was adjusted to 3.20 with aqueous ammonia to prepare a surface treatment agent having the composition shown in Table 1.

[0754] The above-mentioned solder rise rate evaluation test was performed using the obtained surface treatment agent, and the solder rise rate (%) was measured. The reflow conditions were as described in Table 1, the peak temperature was set to 260° C., and the heating was performed twice.

[0755] The test results are shown in Table 1.

[0756] (Examples 2 to 16, Comparative Examples 1 to 4)

[0757] A surface treatment agent was prepared in the same manner as in Example 1 according to the composition described in Tables 1 and 2. The solder rise rate evaluation test was carried out using the obtained surface treatment agent under the treatment conditions described in Tables 1 and 2, and the solder rise rate (%) was measured.

[0758] The test results are shown in Tables 1 and 2.

[0759]

[0760]

[0761] From the comparison between Examples 1 to 4 and Comparative Example 1, Examples 5 to 8 and Comparative Example 2, Examples 9 to 12 and Comparative Example 3, and Examples 13 to 16 and Comparative Example 4, it can be seen that the solder rise rate is improved by containing an imidazole compound (I) or a benzimidazole compound (II) and a triazole compound (III) in the surface treatment agent. Therefore, it can be seen that the chemically generated coating obtained by the surface treatment agents of Examples 1 to 16 has excellent heat resistance.

[0762] (Examples 17 to 20, Comparative Examples 5 to 8)

[0763] A surface treatment agent was prepared in the same manner as in Example 1 according to the composition described in Table 3. The solder rise rate evaluation test was carried out using the obtained surface treatment agent under the treatment conditions described in Table 3, and the solder rise rate (%) was measured.

[0764] The results of these tests are shown in Table 3.

[0765]

[0766] From the comparison between Example 17 and Comparative Example 5, Example 18 and Comparative Example 6, Example 19 and Comparative Example 7, and Example 20 and Comparative Example 8, it can be seen that in a system containing bromide ions and iodide ions as halide ions, the solder rise rate is also improved by containing an imidazole compound (I) or a benzimidazole compound (II) and a triazole compound (III) in the surface treatment agent.

[0767] (Examples 21 to 30, Comparative Examples 9 to 18)

[0768] Similar to Example 1, a surface treatment agent was prepared according to the composition described in Tables 4 to 5, and the solder rise rate evaluation test was carried out using the obtained surface treatment agent under the treatment conditions described in Tables 4 to 5 to measure the solder rise rate (%).

[0769] The test results are shown in Tables 4-5.

[0770]

[0771]

[0772] When 4-(3,4-dichlorophenyl)-5-methyl-2-nonylimidazole (A-1), 2-phenyl-4-(1-naphthyl)-5-methylimidazole (A-2) and 5-methyl-4-phenyl-2-(2-thienyl)imidazole (A-3) are added as the imidazole compound (I) and 6-chloro-2-(3,4-dichlorophenylmethyl)benzimidazole (B-2) and 2-(2-naphthylmethyl)benzimidazole (B-3) are used as the benzimidazole compound (II), the solder rise rate is also improved by containing the imidazole compound (I) or the benzimidazole compound (II) and the triazole compound (III) in the surface treatment agent.

[0773] (Examples 31-32, Comparative Examples 19-20)

[0774] A surface treatment agent was prepared in the same manner as in Example 1 according to the composition described in Table 6. The solder rise rate evaluation test was carried out using the obtained surface treatment agent under the treatment conditions described in Table 6, and the solder rise rate (%) was measured.

[0775] The results of these tests are shown in Table 6.

[0776]

[0777] Comparison between Example 31 and Comparative Example 19, and between Example 32 and Comparative Example 20, shows that in a system containing metal ions, the solder rise rate is also improved by including the imidazole compound (I) and the triazole compound (III) in the surface treatment agent.

[0778] Although the present invention is described in detail with reference to specific embodiments, it is apparent to those skilled in the art that various changes and modifications can be made without departing from the spirit and scope of the present invention. This application is based on Japanese patent application (Japanese patent application 2022-054331) filed on March 29, 2022, the contents of which are incorporated herein by reference.

[0779] Industrial Applicability

[0780] According to the present invention, a surface treatment agent and a surface treatment method can be provided for improving solderability by forming a chemical conversion coating having excellent heat resistance and wettability with solder on the surface of copper or copper alloy constituting a circuit portion of a printed wiring board when electronic components are joined to the printed wiring board using solder.

Claims

1. A surface treatment agent for copper or copper alloy, wherein: The surface treatment agent contains: An imidazole compound represented by the following chemical formula (I) or a benzimidazole compound represented by the following chemical formula (II), and A triazole compound represented by the following chemical formula (III), In formula (I), R1 represents a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a cycloalkyl group, a phenyl group which may have a substituent, a naphthyl group which may have a substituent, a benzyl group which may have a substituent, a naphthylmethyl group, -CH-(Ph)2, -(CH2) k -Ph, thienyl, thienylmethyl, furyl or pyridyl, wherein Ph represents a phenyl group which may have a substituent, and k represents an integer of 2 to 5, R2 are the same or different and represent a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a cycloalkyl group, a phenyl group which may have a substituent, a naphthyl group which may have a substituent, a thienyl group or a furyl group, except that R2 are both hydrogen atoms. In formula (II), R3 represents a linear or branched alkyl group having 1 to 18 carbon atoms, -(CH2) m -Ph, -(CH2) m -Np or a group represented by the following formula (1), Ph represents a phenyl group which may have a substituent, Np represents a naphthyl group which may have a substituent, and m represents an integer of 1 to 5, In formula (1), m represents an integer of 1 to 5, R4 are the same or different and represent a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, a nitro group or a halogen atom, In formula (III), R5 and R6 are the same or different and represent a hydrogen atom, a linear or branched alkyl group having 1 to 18 carbon atoms, an amino group, a phenyl group which may have a substituent, a benzyl group which may have a substituent, a naphthyl group, a pyridyl group or a group represented by the following formula (2), except that R5 and R6 are both groups represented by the following formula (2), In formula (2), t represents an integer from 0 to 12, R7 represents a hydrogen atom, a benzyl group or -(CH2) n -COOH, n represents an integer of 1-5.

2. The surface treatment agent for copper or copper alloy according to claim 1, wherein The surface treatment agent further contains halide ions.

3. The surface treatment agent for copper or copper alloy according to claim 2, wherein: The halide ions are chloride ions.

4. The surface treatment agent for copper or copper alloy according to any one of claims 1 to 3, wherein The surface treatment agent further contains zinc ions.

5. The surface treatment agent for copper or copper alloy according to any one of claims 1 to 4, wherein The triazole compound represented by the chemical formula (III) is contained in a molar ratio of 0.005 to 3.0 relative to the imidazole compound represented by the chemical formula (I) or the benzimidazole compound represented by the chemical formula (II).

6. The surface treatment agent for copper or copper alloy according to any one of claims 1 to 5, wherein The pH of the surface treatment agent is 2-5.